Sheehan, Stephanie A.
Retzbach, Edward P.
Shen, Yongquan
Krishnan, Harini
Goldberg, Gary S.
Funding for this research was provided by:
National Institutes of Health (CA235347)
Osteopathic Heritage Foundation
New Jersey Health Foundation (PC11-21CV)
Camden Health Research Initiative
Article History
Received: 21 October 2021
Accepted: 6 December 2021
First Online: 17 February 2022
Declarations
:
: Not applicable.
: Not applicable.
: GSG has board membership, intellectual property, and ownership in Sentrimed, Inc. which is developing agents that target PDPN to treat diseases including cancer and arthritis. Other authors declare no competing interests.